$MEDP
Medpace Holdings, Inc.
A volume-weighted average price line from the last reported earnings date through today.
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
- CEO
- Dr. August James Troendle M.D.
- Employees
- 6,300
- Headquarters
- Cincinnati, OH
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Website
- medpace.com
Key stats
- Market Cap
- $13.35B
- P/E Ratio
- 29.41
- Avg Volume (3M)
- 364.32K
- EPS
- $15.89
- Day's Range
- $466.40 – $479.30
Fundamentals as of Jun 15, 2026